Xenetic

-$0.0018 (-0.18%) As of 8:30 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company, which engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.

CEO
Jeffrey F. Eisenberg
Employees
4
Headquarters
Framingham, Massachusetts
Founded
2011

XBIO Key Statistics

Market cap
13.78M
Price-Earnings ratio
—
Dividend yield
—
Average volume
122.74K
High today
$1.03
Low today
$0.9751
Open price
$1.00
Volume
59.80K
52 Week high
$5.68
52 Week low
$0.90

XBIO Earnings

-$1.20
-$0.80
-$0.40
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure